• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Glenmark Pharmaceuticals Limited — Updates, 02-07-2026: Press Release

    02-07-2026 | 08:35 am

    Glenmark's subsidiary advanced its multi-country Phase 3 trial for Trastuzumab rezetecan in platinum-resistant ovarian cancer. India began patient enrollment, with Australia and South Korea to follow. This pivotal move enhances Glenmark's oncology pipeline, targeting a significant unmet medical need.

    No comments yet. Be the first to comment!

    All announcements from Glenmark Pharmaceuticals Limited